Compounds > pioglitazone
Page last updated: 2024-08-16

pioglitazone and citric acid, anhydrous

pioglitazone has been researched along with citric acid, anhydrous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mallika, J; Priya, VV; Surapaneni, KM1
Mallika, J; Surapaneni, KM; Vishnu Priya, V1

Other Studies

2 other study(ies) available for pioglitazone and citric acid, anhydrous

ArticleYear
Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
    European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:18

    Topics: Animals; Antioxidants; Citric Acid; Cytochrome P-450 CYP2E1; Enzyme Inhibitors; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pioglitazone; Quercetin; Rats; Rats, Wistar; Reactive Oxygen Species; Thiazolidinediones; Treatment Outcome

2014
Effect of pioglitazone, quercetin, and hydroxy citric acid on vascular endothelial growth factor messenger RNA (VEGF mRNA) expression in experimentally induced nonalcoholic steatohepatitis (NASH).
    Turkish journal of medical sciences, 2015, Volume: 45, Issue:3

    Topics: Analysis of Variance; Animals; Antioxidants; Calcium Chelating Agents; Citric Acid; Disease Models, Animal; Hypoglycemic Agents; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Pioglitazone; Quercetin; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones; Vascular Endothelial Growth Factor A

2015